Try The Drug Club risk-free for 30 days Trial terms

Doxycycline Hyclate — Membership Pricing

Doxycycline Hyclate is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.

Doxycycline Hyclate Pricing

Pricing typePrice
TheDrugClubMembership pricing may be available
Typical Retail$74.00

Membership pricing may be available; confirm the price with the dispensing pharmacy.

About Doxycycline Hyclate

Doxycycline Hyclate is a prescription medication. Ask your doctor if Doxycycline Hyclate is right for you.

Other strengths and forms of Doxycycline

How to Check Doxycycline Hyclate Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Doxycycline Hyclate at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

What Doxycycline Hyclate is approved for (FDA label)

To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Treatment: Doxycycline is indicated for the treatment of the following infections: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae . Respiratory tract infections caused by Mycoplasma pneumoniae. Lymphogranuloma venereum caused by Chlamydia trachomatis.

Source: Read the full FDA label on DailyMed. Label effective date: September 15, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Doxycycline Hyclate (FDA label)

Due to oral doxycycline’s virtually complete absorption, side effects of the lower bowel, particularly diarrhea, have been infrequent. The following adverse reactions have been observed in patients receiving tetracyclines: Gastrointestinal: anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, inflammatory lesions (with monilial overgrowth) in the anogenital region, and pancreatitis. Hepatotoxicity has been reported rarely. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Superficial discoloration of the adult permanent dentition, reversible upon drug discontinuation and professional dental cleaning has been reported.

Source: FDA prescribing information (DailyMed). Set ID: 051654c7-8ba6-44f2-842c-72f515e9b32d. SPL document ID: 5b86d02d-fb8b-b5a0-e063-6394a90ab78f. Label effective date: September 15, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Doxycycline Hyclate (FDA label)

This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Source: FDA prescribing information (DailyMed). Set ID: 051654c7-8ba6-44f2-842c-72f515e9b32d. SPL document ID: 5b86d02d-fb8b-b5a0-e063-6394a90ab78f. Label effective date: September 15, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Doxycycline Hyclate (FDA label)

Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracyclines in conjunction with penicillin. Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, and iron-containing preparations. Absorption of tetracyclines is impaired by bismuth subsalicylate. Barbiturates, carbamazepine, and phenytoin decrease the half-life of doxycycline. The concurrent use of tetracycline and Penthrane ® (methoxyflurane) has been reported to result in fatal renal toxicity. Concurrent use of tetracycline may render oral contraceptives less effective.

Source: FDA prescribing information (DailyMed). Set ID: 051654c7-8ba6-44f2-842c-72f515e9b32d. SPL document ID: 5b86d02d-fb8b-b5a0-e063-6394a90ab78f. Label effective date: September 15, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial